Works about CICLOPIROX

Results: 67

Antifungal mechanism of action of Schinus lentiscifolius Marchand essential oil and its synergistic effect in vitro with terbinafine and ciclopirox against dermatophytes.

Published in:

Journal of Pharmacy & Pharmacology, 2018, v. 70, n. 9, p. 1216, doi. 10.1111/jphp.12949

By:

Danielli, Letícia J.;
Pippi, Bruna;
Duarte, Jonathaline A.;
Maciel, Ana J.;
Lopes, William;
Machado, Michel M.;
Oliveira, Luis Flávio S.;
Vainstein, Marilene H.;
Teixeira, Mário L.;
Bordignon, Sérgio A. L.;
Fuentefria, Alexandre M.;
Apel, Miriam A.

Publication type:

Article

VIGNETTE IN CONTACT DERMATOLOGY Allergic contact dermatitis from ciclopirox olamine.

Published in:

Australasian Journal of Dermatology, 2001, v. 42, n. 2, p. 145, doi. 10.1046/j.1440-0960.2001.00501.x

By:

Foti, Caterina;
Diaferio, Annalisa;
Bonamonte, Domenico

Publication type:

Article

Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.

Published in:

Mycoses, 2015, v. 58, n. 10, p. 610, doi. 10.1111/myc.12369

By:

Seidl, Hans P.;
Jäckel, Andreas;
Müller, Julia;
Schaller, Martin;
Borelli, Claudia;
Polak, Annemarie

Publication type:

Article

Comparison of user-friendliness and treatment cost of Loceryl<sup>®</sup> vs. Ciclopoli<sup>®</sup> - a patient's perspective.

Published in:

Mycoses, 2015, v. 58, n. 10, p. 632, doi. 10.1111/myc.12371

By:

Schaller, M.;
Braunsdorf, C.;
Mailänder‐Sanchez, D.;
Jäckel, A.;
Müller, J.;
Borelli, C.

Publication type:

Article

Contact dermatitis due to ciclopiroxolamine.

Published in:

2006

By:

Romano, Clara;
Ghilardi, A.;
Calò, D.;
Maritati, E.

Publication type:

Letter

Dystrophic onychomycosis due to Microsporum gypseum.

Published in:

2006

By:

Romano, Clara;
Ghilardi, A.;
Fimiani, M.

Publication type:

Letter

In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.

Published in:

Mycoses, 2006, v. 49, n. 3, p. 159, doi. 10.1111/j.1439-0507.2006.01228.x

By:

Sigle, H. C.;
Schäfer-Korting, M.;
Korting, H. C.;
Hube, B.;
Niewerth, M.

Publication type:

Article

Tinea capitis favosa in Poland.

Published in:

Mycoses, 2004, v. 47, n. 5/6, p. 257, doi. 10.1111/j.1439-0507.2004.00985.x

By:

Niczyporuk, W.;
Krajewska-Kulak, E.;
Lukaszuk, C.

Publication type:

Article

Ciclopirox in the treatment of seborrhoeic dermatitis.

Published in:: Mycoses, 2002, v. 45, p. 238
Publication type:: Article

Ciclopirox olamine directly scavenges hydroxyl radical.

Published in:

International Journal of Dermatology, 2008, v. 47, n. 1, p. 15, doi. 10.1111/j.1365-4632.2007.03359.x

By:

Sato, Emiko;
Kohno, Masahiro;
Nakashima, Takuji;
Niwano, Yoshimi

Publication type:

Article

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.

Published in:

International Journal of Dermatology, 2006, v. 45, n. 1, p. 66, doi. 10.1111/j.1365-4632.2004.02331.x

By:

Gupta, Aditya K.;
Nicol, Karyn A.

Publication type:

Article

Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.

Published in:

International Journal of Dermatology, 2005, v. 44, n. 7, p. 590, doi. 10.1111/j.1365-4632.2004.02559.x

By:

Gupta, Aditya K.;
Skinner, Alayne R.;
Cooper, Elizabeth A.

Publication type:

Article

Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: Results of a randomized, double-blind, vehicle-controlled trial.

Published in:

International Journal of Dermatology, 2004, v. 43, p. 9, doi. 10.1111/j.1461-1244.2004.02381.x

By:

Altmeyer, Peter;
Hoffmann, Klaus

Publication type:

Article

Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.

Published in:

International Journal of Dermatology, 2004, v. 43, p. 3, doi. 10.1111/j.1461-1244.2004.02380.x

By:

Gupta, Aditya K.;
Plott, Todd

Publication type:

Article

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: Results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.

Published in:

International Journal of Dermatology, 2004, v. 43, p. 13, doi. 10.1111/j.1461-1244.2004.02382.x

By:

Abeck, Dietrich

Publication type:

Article

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: Results of a double-blind, vehicle-controlled trial.

Published in:

International Journal of Dermatology, 2004, v. 43, p. 17, doi. 10.1111/j.1461-1244.2004.02409.x

By:

Lebwohl, Mark;
Plott, Todd

Publication type:

Article

Ciclopirox 1% shampoo is a safe and effective treatment for seborrheic dermatitis.

Published in:

International Journal of Dermatology, 2004, v. 43, p. 1, doi. 10.1111/j.1461-1244.2004.02383.x

By:

Gupta, Aditya K.;
Lebwohl, Mark

Publication type:

Article

Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel.

Published in:

International Journal of Dermatology, 2003, p. 23, doi. 10.1046/j.1365-4362.42.s1.1.x

By:

Gupta, Aditya K.;
Skinner, Alayne R.;
Cooper, Elizabeth A.

Publication type:

Article

Ciclopirox for the treatment of superficial fungal infections: a review.

Published in:

International Journal of Dermatology, 2003, p. 3, doi. 10.1046/j.1365-4362.42.s1.2.x

By:

Gupta, Aditya K.;
Skinner, Alayne R.

Publication type:

Article

Ciclopirox gel: an update.

Published in:

International Journal of Dermatology, 2003, p. 1, doi. 10.1046/j.1365-4362.42.s1.3.x

By:

Gupta, Aditya K.

Publication type:

Article

Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.

Published in:

International Journal of Dermatology, 2003, p. 11, doi. 10.1046/j.1365-4362.42.s1.4.x

By:

Kokjohn, Katrina;
Bradley, Mary;
Griffiths, Brian;
Ghannoum, Mahmoud

Publication type:

Article

Ciclopirox gel for seborrheic dermatitis of the scalp.

Published in:

International Journal of Dermatology, 2003, p. 19, doi. 10.1046/j.1365-4362.42.s1.5.x

By:

Aly, Raza;
Katz, H. Irving;
Kempers, Steven E.;
Lookingbill, Donald P.;
Lowe, Nicholas;
Menter, Alan;
Morman, Manuel;
Savin, Ronald C.;
Wortzman, Mitchell

Publication type:

Article

Ciclopirox gel in the treatment of patients with interdigital tinea pedis.

Published in:

International Journal of Dermatology, 2003, p. 29, doi. 10.1046/j.1365-4362.42.s1.6.x

By:

Aly, Raza;
Fisher, George;
Katz, H. Irving;
Levine, Norman;
Lookingbill, Donald P;
Lowe, Nicholas;
Menter, Alan;
Morman, Manuel;
Pariser, David M;
Roth, Harry L;
Savin, Ronald C;
Shavin, Joel S;
Stewart, Daniel;
Taylor, J. Richard;
Tucker, Stephen;
Wortzman, Mitchell

Publication type:

Article

Ciclopirox: an overview.

Published in:

International Journal of Dermatology, 2001, v. 40, n. 5, p. 305, doi. 10.1046/j.1365-4362.2001.01156.x

By:

Gupta, Aditya K.

Publication type:

Article

Onychomycosis Due to Neoscytalidium Treated with Oral Terbinafine, Ciclopirox Nail Lacquer and Nail Abrasion: A Pilot Study of 25 Patients.

Published in:

Mycopathologia, 2013, v. 175, n. 1/2, p. 75, doi. 10.1007/s11046-012-9580-5

By:

Cursi, Ígor;
Silva, Roberta;
Succi, Isabella;
Bernardes-Engemann, Andréa;
Orofino-Costa, Rosane

Publication type:

Article

ルリコナゾール爪外用液のin vitro爪透過性試験およびスライス阻止円法による爪中薬物濃度分布および抗真菌活性評価

Published in:

Medical Mycology Journal, 2016, v. 57, n. 1, p. J19

By:

Shimamura Tsuyoshi;
Miyamae Akiko;
Arai Masakazu;
Minemura Aya;
Nozawa Akira;
Kubota Nobuo

Publication type:

Article

Ciclopirox: Recent Nonclinical and Clinical Data Relevant to its Use as a Topical Antimycotic Agent.

Published in:: Drugs, 2010, v. 70, n. 16, p. 2133, doi. 10.2165/11538110-000000000-00000
Publication type:: Article

Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.

Published in:

PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161509

By:

Wu, Jianrong;
Liu, Huajun;
Zhang, Ge;
Gu, Ling;
Zhang, Yanle;
Gao, Ju;
Wei, Yuquan;
Ma, Zhigui

Publication type:

Article

Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.

Published in:

PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159661

By:

Matsuda, Yoshiki;
Sugiura, Keita;
Hashimoto, Takashi;
Ueda, Akane;
Konno, Yoshihiro;
Tatsumi, Yoshiyuki

Publication type:

Article

D-optimal Design and Development of Microemulsion Based Transungual Drug Delivery Formulation of Ciclopirox Olamine for Treatment of Onychomycosis.

Published in:

Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 4, p. 498, doi. 10.4172/pharmaceutical-sciences.1000145

By:

CHOUHAN, P.;
SAINI, T. R.

Publication type:

Article

In Vitro Transungual Permeation of Ciclopirox from a Hydroxypropyl Chitosan-Based, Water-Soluble Nail Lacquer.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 1, p. 11, doi. 10.1081/DDC-200043935

By:

Monti, Daniela;
Saccomani, L.;
Chetoni, P.;
Burgalassi, S.;
Saettone, M. F.;
Mailland, F.

Publication type:

Article

Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 5, p. 6854, doi. 10.3892/ol.2018.9472

By:

Al-Dali, Ahmad M.;
Weiher, Hans;
Schmidt-Wolf, Ingo G.H.

Publication type:

Article

Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy.

Published in:

Pediatric Dermatology, 2013, v. 30, n. 3, p. 316, doi. 10.1111/pde.12064

By:

Friedlander, Shiela Fallon;
Chan, Yuin C.;
Chan, Yiong H.;
Eichenfield, Lawrence F.

Publication type:

Article

A Randomized, Double-Blind Study Comparing the Efficacy of Selenium Sulfide Shampoo 1% and Ciclopirox Shampoo 1% as Adjunctive Treatments for Tinea Capitis in Children.

Published in:

Pediatric Dermatology, 2010, v. 27, n. 5, p. 459, doi. 10.1111/j.1525-1470.2010.01093.x

By:

Chen, Catherine;
Koch, Laine H.;
Dice, James E.;
Dempsey, Kimberly K.;
Moskowitz, Alan B.;
Barnes-Eley, Myra L.;
Hubbard, Thomas W.;
Williams, Judith V.

Publication type:

Article

Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.

Published in:

PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210547

By:

Conley, Zachary C.;
Carlson-Banning, Kimberly M.;
Carter, Ashley G.;
de la Cova, Alejandro;
Song, Yongcheng;
Zechiedrich, Lynn

Publication type:

Article

Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.

Published in:

Pflügers Archiv: European Journal of Physiology, 2016, v. 468, n. 11/12, p. 1957, doi. 10.1007/s00424-016-1887-5

By:

Mihailidou, Chrysovalantou;
Chatzistamou, Ioulia;
Papavassiliou, Athanasios;
Kiaris, Hippokratis

Publication type:

Article

Exploring the versatility of ciclopirox - from anti-fungal to anticancer agent and beyond.

Published in:

European Journal of Clinical & Experimental Medicine, 2023, v. 21, n. 4, p. 896, doi. 10.15584/ejcem.2023.4.26

By:

Singh, Dhishank;
Kaur, Ginpreet;
Chintamaneni, Meena;
Joshi, Hemant;
Ramniwas, Seema;
Tuli, Hardeep Singh

Publication type:

Article

Ciclopirox olamine: an antifungal alternative against cryptococcosis.

Published in:

Letters in Applied Microbiology, 2010, v. 51, n. 5, p. 485, doi. 10.1111/j.1472-765X.2010.02914.x

By:

Oliveira, P. C.;
Medeiros, C. S. Q.;
Macêdo, D. P. C.;
Andrade, S. L.;
Correia, M. T. A. L.;
Mesquita, S. D.;
Lima-Neto, R. G.;
Neves, R. P.

Publication type:

Article

Sequential Injection Analysis of Ciclopirox Olamine Using Lanthanide-Sensitized Luminescence Detection.

Published in:

Analytical Letters, 2013, v. 46, n. 11, p. 1816, doi. 10.1080/00032719.2012.703274

By:

Llorent-Martínez, E.J.;
Jiménez-López, J.;
Delgado-Blanca, I.;
Ortega-Barrales, P.;
Ruiz-Medina, A.

Publication type:

Article

Ciclopiroxolamine Cream 1% in the Treatment of Seborrhoeic Dermatitis: A Double-Blind, Parallel-Group Comparison with Ketoconazole and Vehicle in a Confirmatory Trial.

Published in:

Clinical Drug Investigation, 2002, v. 22, n. 3, p. 167, doi. 10.2165/00044011-200222030-00003

By:

Unholzer, A.;
Schinzel, S.;
Nietsch K.-H.;
Jung, G.E.;
Korting, H.C.

Publication type:

Article

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

Published in:

Science Translational Medicine, 2018, v. 10, n. 459, p. 1, doi. 10.1126/scitranslmed.aat7467

By:

Urquiza, Pedro;
Laín, Ana;
Sanz-Parra, Arantza;
Moreno, Jorge;
Bernardo-Seisdedos, Ganeko;
Dubus, Pierre;
González, Esperanza;
Gutiérrez-de-Juan, Virginia;
García, Sandra;
Eraña, Hasier;
San Juan, Itxaso;
Macías, Iratxe;
Ben Bdira, Fredj;
Pluta, Paula;
Ortega, Gabriel;
Oyarzábal, Julen;
González-Muñiz, Rosario;
Rodríguez-Cuesta, Juan;
Anguita, Juan;
Díez, Emilio

Publication type:

Article

Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 5, p. 655, doi. 10.1093/jac/dki105

By:

Robin E. B. Lee;
Teresa T. Liu;
Katherine S. Barker;
Richard E. Lee;
P. David Rogers

Publication type:

Article

Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 5, p. 663, doi. 10.1093/jac/dki089

By:

Hans-Christian Sigle;
Sascha Thewes;
Markus Niewerth;
Hans Christian Korting;
Monika Schfer-Korting;
Bernhard Hube

Publication type:

Article

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.

Published in:

Frontiers in Microbiology, 2015, p. 1, doi. 10.3389/fmicb.2015.00282

By:

Rangel-Vega, Adrián;
Bernstein, Lawrence R.;
Mandujano-Tinoco, Edna Ayerim;
García-Contreras, Silvia Julieta;
García-Contreras, Rodolfo

Publication type:

Article

Effects of VEGF on the Blood-Brain Barrier Disruption Caused by Hyperosmolarity.

Published in:

Pharmacology, 2008, v. 82, n. 3, p. 187, doi. 10.1159/000151433

By:

Chi, Oak Z.;
Hunter, Christine;
Liu, Xia;
Tan, Tao;
Weiss, Harvey R.

Publication type:

Article

Ciclopirox: a new topical pyrodonium antimycotic agent.

Published in:

British Journal of Dermatology, 1976, v. 95, n. 1, p. 83, doi. 10.1111/j.1365-2133.1976.tb15537.x

By:

Sehgal, V. N.

Publication type:

Article

Nail dermoscopy (onychoscopy) is useful in diagnosis and treatment follow-up of the nail mixed infection caused by Pseudomonas aeruginosa and Candida albicans.

Published in:

2018

By:

Romaszkiewicz, Alicja;
Sławińska, Martyna;
Sobjanek, Michał;
Nowicki, Roman J.

Publication type:

Case Study

Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.

Published in:

Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii, 2015, v. 32, n. 1, p. 40, doi. 10.5114/pdia.2014.40968

By:

Tabara, Katarzyna;
Szewczyk, Anna E.;
Bienias, Wojciech;
Wojciechowska, Agnieszka;
Pastuszka, Marta;
Oszukowska, Magdalena;
Kaszuba, Andrzej

Publication type:

Article

Degradation and Impurity Profile Study of Ciclopirox Olamine after Pre-column Derivatization: A Risk Based Approach.

Published in:

Journal of Chromatographic Science, 2017, v. 55, n. 9, p. 899, doi. 10.1093/chromsci/bmx047

By:

Baghel, Madhuri;
Rajput, Sadhana

Publication type:

Article

Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2013, v. 27, n. 2, p. e153, doi. 10.1111/j.1468-3083.2012.04529.x

By:

Monti, D.;
Herranz, U.;
Dal Bo, L.;
Subissi, A.

Publication type:

Article